Androgen Deprivation Therapy

Also known as: Hormone suppression therapy / Androgen-deprivation therapy / Antiandrogen therapy / Androgen deprivation therapy (procedure)

DrugDrug NameDrug Description
DB05812AbirateroneAn antiandrogen used in the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer.
DB06643DenosumabA RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures.
DB16778Lutetium Lu-177 vipivotide tetraxetanA radioligand therapeutic agent used to treat prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer in adults.
DrugDrug NamePhaseStatusCount
DB08899Enzalutamide1Not Yet Recruiting1
DB11853Relugolix1Not Yet Recruiting1
DB00014Goserelin3Recruiting1
DB00007Leuprolide3Recruiting1
DB06825Triptorelin3Recruiting1
DB01128Bicalutamide4Recruiting1
DB08899Enzalutamide4Recruiting1
DB00499Flutamide4Recruiting1
DB00644Gonadorelin4Recruiting1
DB00014Goserelin4Recruiting1
DB00007Leuprolide4Recruiting1
DB00644GonadorelinNot AvailableActive Not Recruiting1
DB00014GoserelinNot AvailableActive Not Recruiting1
DB00014GoserelinNot AvailableTerminated1